Welcome to the website dedicated to the Addiction Awareness Scales

The addiction awareness scales measure the core dimensions of clinical insight in addictive disorders, including general illness awareness, symptom attribution, awareness of need for treatment, and awareness of negative consequences attributable to the illness. The addiction awareness scales were designed to assess clinical insight in addictive disorders, including alcohol (AAS^©), nicotine (NAS^©), gambling (GAS^©), and other substances (SAS^©).

The AAS^©, SAS^©, NAS^©, and GAS^© scales are the first illness awareness scales in addiction. The 7-item self-report scales are easy to complete and can be done in less than 2 minutes. These addiction awareness scales show good internal consistency, reliability and validity. Using a 10-point Likert scale for each item, the addiction awareness scales have the capacity to detect small, temporally sensitive changes in insight.

The AAS^©, SAS^©, NAS^©, and GAS^© scales are available for download. Please see the terms of use below.

AAS^©, SAS^©, NAS^©, and GAS^© scales are owned by the Centre for Addiction & Mental Health (CAMH), Toronto, Canada, published 2020 (Canadian Copyright Registration No. 1174237, No.1174234, No. 1174238, No. 1174236; Registered September 24, 2020). Please read the content below and click the 'Accept and Continue' button to acknowledge the terms and usage of www.illnessawarenessscales.com and the related addiction awareness scales. Thank you for your interest and support.

PERMISSION TO USE www.illnessawarenessscales.com and the related AAS^©, SAS^©, NAS^©, and GAS^© scales are as follows:

• Universities/Foundations/HealthProfessionals/Hospitals/Clinics/Public Health Institutes
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed WITHOUT permission subject to the exception below for entities funded by a commercial entity or pharma. The test should be made available free of charge to patients. Written permission from CAMH and Licensing Agreement with CAMH is required if funded by a commercial entity or pharma.
• Commercial Entity/Pharma:
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed only WITH prior written permission from CAMH and Licensing Agreement with CAMH. The test should be made available free of charge to patients.

• Universities/Foundations/HealthProfessionals/Hospitals/Clinics/Public Health Institutes
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed WITHOUT permission subject to the exception below for entities funded by a commercial entity or pharma. The test should be made available free of charge to patients. Written permission from CAMH and Licensing Agreement with CAMH is required if funded by a commercial entity or pharma.
• Commercial Entity/Pharma:
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed only WITH prior written permission from CAMH and Licensing Agreement with CAMH. The test should be made available free of charge to patients.

• Universities/Foundations/HealthProfessionals/Hospitals/Clinics/Public Health Institutes
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed only WITH prior written permission from CAMH. The test should be made available free of charge to patients. Written permission from CAMH and Licensing Agreement with CAMH is required if funded by a commercial entity or pharma.
• Commercial Entity/Pharma sponsored research:
  AAS^©, SAS^©, NAS^©, and GAS^© scales may be used, reproduced, and distributed only WITH prior written permission from CAMH and Licensing Agreement with CAMH. The test should be made available free of charge to patients.

For more information, please contact:
Dr. Philip Gerretsen, MD, PhD, FRCPC
philgerretsen@yahoo.com; philip.gerretsen@camh.ca